MONTERREY, Mexico, Sept. 23, 2026 (GLOBE NEWSWIRE) — Fomento Económico Mexicano, S.A.B. de C.V. (“FEMSA” or the “Company”) (NYSE: FMX; BMV: FEMSAUBD, FEMSAUB) announced the placement of a Swiss Franc denominated offering of Senior Unsecured Bonds in the Swiss bond market, to be listed on SIX Swiss Exchange. FEMSA successfully issued CHF $300 million in a 5-year senior unsecured bonds. The bonds will bear interest at an annual rate of 107 basis points over the relevant benchmark rate, for a yield of 1.73%. The issuance received credit ratings of BBB+ from S&P Global Ratings and A from Fitch Ratings. The proceeds from this issuance will be used for general corporate purposes, improving FEMSA’s cost of debt and increasing its financial flexibility under extremely favorable conditions. This press release does not constitute an...

WINTER PARK, Fla., Sept. 23, 2026 (GLOBE NEWSWIRE) — Streamex Corp. (“Streamex” or the “Company”) (NASDAQ: STEX), a technology company building the future of the commodity markets through tokenization, will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Fall 2026 Investor Conference, taking place virtually on September 29, 2026. Company Webcast The webcast presentation will take place at 3:30 p.m. ET on Tuesday, September 29, 2026. The webcast can be accessed by visiting the conference website at https://lythampartners.com/fall2026/ or directly at https://app.webinar.net/E2lpqML7me1. The webcast will also be available for replay following the event on the company’s website at https://ir.streamex.com/news-events/events. 1×1 Meetings Management will be participating in...

SYDNEY, Australia, Sept. 23, 2026 (GLOBE NEWSWIRE) — GMEX Robotics Corporation (Nasdaq: GMEX) (the “Company”), today announced that it will effect a share consolidation of all of its issued and unissued Class A ordinary shares, Class B ordinary shares and Class C ordinary shares, of US$0.8064 par value each, at a ratio of 1-for-9, effective on September 28, 2026 (the “Share Consolidation”). Immediately following Share Consolidation, the Company’s par value of all of its issued and unissued shares will be reduced to US$0.000001 per share (the “Reduction of Par Value”). The Share Consolidation and the Reduction of Par Value will apply to the Company’s Class A Ordinary Shares, Class B Ordinary Shares and Class C Ordinary Shares. Except for the changes expressly described in this announcement, the rights attaching to each of shares...

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q3 2026 Aide Memoire is available on the “Investors” page on its website. Q3 2026 Aide Memoire Teva has compiled this document with public information that was previously provided by Teva in order to assist investors ahead of third quarter 2026 results, which are expected to be released on Tuesday, November 3, 2026, at 7:00 a.m. ET, followed by a conference call at 8:00 a.m. ET on the same day. This document is based on Teva’s prior results, management’s previous commentary about Teva’s business outlook and data from select independent sources. About TevaTeva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company,...

TEL AVIV, Israel and PARSIPPANY, N.J., Sept. 23, 2026 (GLOBE NEWSWIRE) — Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its third quarter 2026 financial results on Tuesday, November 3, 2026, at 7:00 a.m. ET. Following the release, Teva will conduct a conference call and live webcast on the same day, at 8:00 a.m. ET. In order to participate, please register in advance here to obtain a local or toll-free phone number and your personal pin. A live webcast of the call will be available on Teva’s website at: https://ir.tevapharm.com/Events-and-Presentations. Following the conclusion of the call, a replay of the webcast will be available within 24 hours on Teva’s website. About Teva Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into...

BOSTON HEIGHTS, Ohio, Sept. 23, 2026 (GLOBE NEWSWIRE) — Arhaus, Inc. (“Arhaus” or the “Company”) (NASDAQ: ARHS), a premium home furnishing brand known for responsibly sourced, artisan-crafted products and heirloom-quality design, today announced its participation in the following investor event: Bank of America Global Research Nashville Store Tour and Consumer EventOctober 6, 2026Nashville, Tennessee Vice President, Head of Investor Relations Tara Atwood Saja will participate in in the event at the Company’s Nashville showroom. The event will not be webcast. About Arhaus Founded in 1986 by Chief Executive Officer John Reed and his father, Arhaus is a premium home furnishings brand built on a simple idea: furniture and décor should be responsibly sourced, lovingly made, and built to last. Arhaus operates a vertically integrated...

Serina Therapeutics, Inc.Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event “A New Approach to Advanced Parkinson’s Disease: Serina Discusses SER-252’s Clinical Progress”Featuring Serina Therapeutics’ CEO – Thursday, September 24, 202610M people in the world currently living with Parkinson’s disease with no major clinical advances in 50+ years Meet with Serina’s CEO Steven Ledger Register at AdvancingParkinsonsDisease.TribePublic.comHUNTSVILLE, AL, Sept. 23, 2026 (GLOBE NEWSWIRE) — Serina Therapeutics, Inc. (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology enabling drug product candidates to treat neurological diseases and other indications, is pleased to announce...

LITTLETON, Mass., Sept. 23, 2026 (GLOBE NEWSWIRE) — Precision Optics Corporation, Inc. (Nasdaq: POCI) (the “Company”), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company’s fourth quarter and full year fiscal 2026 financial results on Monday, September 28, 2026, at 5:00 p.m. ET. The Company intends to release its financial results and to file its 10-K after the close of the market on Monday, September 28, 2026, followed by the conference call. Conference Call Details Date and Time: Monday, September 28, 2026, at 5:00 p.m. ET. Call-in Information: Interested parties can access the conference call by dialing 1-844-735-3662 (USA/Canada toll-free) or 1-412-317-5705 (international). Live...

The Vision Centre Brings Industry Leading Innovation to Accelerate Breakthroughs in Eye Care SAN RAMON, Calif., Sept. 23, 2026 (GLOBE NEWSWIRE) — CooperCompanies (Nasdaq: COO) today reinforced its commitment to accelerate growth at CooperVision with the opening of its new global innovation hub, The Vision Centre, and the announcement of six major product advancements that have been accelerated to launch over the next several years:The build-out of the world’s first & only complete family of 1-day contact lenses for myopia control, built on the world’s #1 toric design; A novel premium 1-day silicone hydrogel (SiHy) technology; A next-generation SiHy material in a high-performing monthly contact lens; A differentiated entry 1-day SiHy innovation to drive new fits; The most advanced 1-day SiHy toric multifocal contact...

Investment enhances Teamshares’ programmatic acquisition strategy with flexible, non-dilutive capital NEW YORK, Sept. 23, 2026 (GLOBE NEWSWIRE) — Teamshares (NASDAQ:TMS, the “Company”), a tech-enabled acquiror of high-quality SMEs, announced a significant investment by accounts advised by T. Rowe Price Investment Management, Inc. (“TRPIM”). Teamshares has closed a $225 million preferred equity investment, structured as a newly designated Series A perpetual, non-voting, non-convertible preferred stock (the “Series A Preferred Stock”). The investment proceeds are primarily intended to fund additional acquisitions, core to Teamshares’ programmatic acquisition growth strategy. The definitive documents include the Company’s ability to issue up to an additional $75 million to other institutional investors. Teamshares’ strategic rationale...